BEAM THERAPEUTICS INC's ticker is BEAM and the CUSIP is 07373V105. A total of 242 filers reported holding BEAM THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 1.19 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $46,156 | -21.2% | 1,970 | +11.2% | 0.00% | – |
| Q1 2024 | $58,547 | +37.5% | 1,772 | +13.3% | 0.00% | – |
| Q4 2023 | $42,571 | +176.2% | 1,564 | +144.0% | 0.00% | – |
| Q3 2023 | $15,415 | +40.3% | 641 | +86.3% | 0.00% | – |
| Q2 2023 | $10,984 | +337.6% | 344 | +319.5% | 0.00% | – |
| Q1 2023 | $2,510 | +31.0% | 82 | +67.3% | 0.00% | – |
| Q4 2022 | $1,916 | -52.1% | 49 | -24.6% | 0.00% | – |
| Q3 2022 | $4,000 | – | 65 | +195.5% | 0.00% | – |
| Q2 2022 | $0 | -100.0% | 22 | -99.6% | 0.00% | – |
| Q1 2022 | $289,000 | -28.1% | 5,036 | -0.1% | 0.00% | – |
| Q4 2021 | $402,000 | -23.6% | 5,043 | -16.7% | 0.00% | – |
| Q3 2021 | $526,000 | -29.7% | 6,052 | +4.1% | 0.00% | -100.0% |
| Q2 2021 | $748,000 | +70.4% | 5,812 | +6.0% | 0.00% | – |
| Q1 2021 | $439,000 | +0.7% | 5,483 | +2.4% | 0.00% | – |
| Q4 2020 | $436,000 | +254.5% | 5,352 | +7.0% | 0.00% | – |
| Q3 2020 | $123,000 | – | 5,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MWG Management Ltd. | 2,346,934 | $74,937,603 | 45.33% |
| HSG Holding Ltd | 796,089 | $25,419,122 | 2.91% |
| Deep Track Capital, LP | 1,317,316 | $42,061,900 | 1.95% |
| Redmile Group, LLC | 1,485,199 | $47,422,404 | 1.82% |
| ARK Investment Management | 8,382,595 | $267,656,246 | 1.77% |
| Casdin Capital, LLC | 570,000 | $18,200,100 | 1.59% |
| Yiheng Capital Management, L.P. | 463,800 | $14,809,134 | 0.80% |
| Temasek Holdings (Private) Ltd | 4,317,789 | $137,867,003 | 0.80% |
| Alphabet Inc. | 321,604 | $10,268,815 | 0.55% |
| FARALLON CAPITAL MANAGEMENT LLC | 3,441,522 | $109,887,797 | 0.55% |